Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 11/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 9/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 9/20 | 0.44 |
| ▸ | DPP4 | P27487 | 6/20 | 0.44 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28829367 | 0.86 | — | — | |
| SCHEMBL6313430 | 0.83 | SLC1A2 (0.46) | CA1CA2DPP7DPP8DPP9 | |
| SCHEMBL12478006 | 0.83 | PLA2G2C (0.46) | CA1CA2DPP7DPP8DPP9 | |
| SCHEMBL28226879 | 0.81 | DPP7 (0.43) | CA1CA2DPP7DPP8DPP9 | |
| SCHEMBL3169683 | 0.80 | ALOX15 (0.41) | DPP8DPP9DPP4 | |
| SCHEMBL293527 | 0.78 | TAS1R3 (0.49) | CA1CA2DPP7DPP8DPP9 | |
| SCHEMBL5670726 | 0.78 | CA1 (0.38) | CA1CA2DPP7DPP8DPP9 | |
| SCHEMBL11809597 | 0.78 | CA1 (0.38) | CA1CA2DPP7DPP8DPP9 | |
| SCHEMBL9442358 | 0.77 | GSR (0.47) | DPP7DPP8DPP9 | |
| SCHEMBL27826930 | 0.77 | ENPEP (0.48) | SLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109415593-A | Aqueous coating composition and method for forming metallic appearance coating film using same | 日涂汽车涂料有限公司 | 2019-03-01 | — | — | CN | disclosed |
| CN-107840951-A | A kind of water-based self-initiating On Visible Light Cured Resin and preparation method thereof | 长沙香溪涂料有限公司 | 2018-03-27 | — | — | CN | disclosed |
| CN-107602851-A | A kind of water-based self-initiating On Visible Light Cured Resin and its preparation method and application | 郭文迅 | 2018-01-19 | — | — | CN | disclosed |
| US-8362203-B2 | Non-natural peptides as models for the development of antibiotics | WAYNE STATE UNIVERSITY (US) | 2013-01-29 | — | — | US | disclosed |
| US-20110021748-A1 | Non-Natural Peptides as Models for the Development of Antibiotics | WAYNE STATE UNIVERSITY (US) | 2011-01-27 | — | — | US | disclosed |
| EP-1299347-A2 | METHOD FOR SEPARATING AMMONIAC | BASF AKTIENGESELLSCHAFT (DE) | 2003-04-09 | — | — | EP | disclosed |
| WO-2002008171-A2 | METHOD FOR SEPARATING AMMONIAC | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021748-A1 | Non-Natural Peptides as Models for the Development of Antibiotics | MRPL21, SPOUT1, EMG1 | CA1 4381/4885CA2 4695/4885DPP7 1947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.